Bionomics Ltd Adr Stock Buy Hold or Sell Recommendation
| BNOX Stock | USD 0.30 0.02 7.14% |
Given the investment horizon of 90 days and your conservative risk appetite, our recommendation regarding Bionomics Ltd ADR is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Bionomics Ltd ADR given historical horizon and risk tolerance towards Bionomics. When Macroaxis issues a 'buy' or 'sell' recommendation for Bionomics Ltd ADR, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Bionomics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Bionomics and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Bionomics Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Bionomics |
Execute Bionomics Buy or Sell Advice
The Bionomics recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bionomics Ltd ADR. Macroaxis does not own or have any residual interests in Bionomics Ltd ADR or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bionomics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Bionomics Trading Alerts and Improvement Suggestions
| Bionomics ADR is way too risky over 90 days horizon | |
| Bionomics ADR has some characteristics of a very speculative penny stock | |
| Bionomics ADR appears to be risky and price may revert if volatility continues | |
| Bionomics ADR has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 20 K. Net Loss for the year was (15.49 M) with loss before overhead, payroll, taxes, and interest of (18.96 M). | |
| Bionomics Ltd ADR currently holds about 33.56 M in cash with (14.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.46, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 34.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: U.S. stocks higher at close of trade Dow Jones Industrial Average up 0.88 percent - MSN |
Bionomics Returns Distribution Density
The distribution of Bionomics' historical returns is an attempt to chart the uncertainty of Bionomics' future price movements. The chart of the probability distribution of Bionomics daily returns describes the distribution of returns around its average expected value. We use Bionomics Ltd ADR price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bionomics returns is essential to provide solid investment advice for Bionomics.
| Mean Return | 0.41 | Value At Risk | -24 | Potential Upside | 11.86 | Standard Deviation | 22.60 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bionomics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Bionomics Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Bionomics, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Bionomics Ltd ADR back and forth among themselves.
| Shares | Armistice Capital, Llc | 2024-09-30 | 1.6 M | Xtx Topco Ltd | 2024-09-30 | 0.0 | Point72 Asset Management, L.p. | 2024-09-30 | 316 K | Ubs Group Ag | 2024-06-30 | 34.9 K | Two Sigma Securities, Llc | 2024-06-30 | 26 K | Beacon Pointe Advisors, Llc | 2024-06-30 | 10 K | Rhumbline Advisers | 2024-06-30 | 2.2 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.6 K | Aspire Private Capital, Llc | 2024-09-30 | 200 | Jpmorgan Chase & Co | 2024-06-30 | 1.0 | Two Sigma Investments Llc | 2024-09-30 | 0.0 |
Bionomics Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (9.4M) | 23.9M | 1.8M | (11.0M) | 505.0K | 694.2K | |
| Free Cash Flow | (3.9M) | (7.5M) | (15.0M) | (14.2M) | (14.7M) | (13.9M) | |
| Depreciation | 2.2M | 1.7M | 766.0K | 770.6K | 663.0K | 1.0M | |
| Other Non Cash Items | 7.1M | 8.7M | (2.6M) | 5.1M | 137.1M | 143.9M | |
| Capital Expenditures | 69.5K | 7.7K | 1.5K | 1.1K | 4.44 | 4.22 | |
| Net Income | (5.8M) | (8.7M) | (15.0M) | (21.2M) | (15.5M) | (14.7M) | |
| End Period Cash Flow | 4.6M | 28.5M | 23.2M | 12.2M | 12.7M | 15.1M | |
| Change To Inventory | (28.3K) | 152.8K | 3.9M | (4.8M) | (4.3M) | (4.1M) | |
| Net Borrowings | (8.3M) | (11.9M) | (174.2K) | (160.0K) | (144.0K) | (151.2K) | |
| Change To Netincome | (3.0M) | (2.4M) | 4.5M | 2.4M | 2.7M | 2.9M |
Bionomics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bionomics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bionomics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bionomics stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.25 | |
β | Beta against Dow Jones | 1.28 | |
σ | Overall volatility | 23.12 | |
Ir | Information ratio | 0.01 |
Bionomics Volatility Alert
Bionomics Ltd ADR is showing large volatility of returns over the selected time horizon. Bionomics Ltd ADR is a potential penny stock. Although Bionomics may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Bionomics Ltd ADR. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Bionomics instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Bionomics Fundamentals Vs Peers
Comparing Bionomics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bionomics' direct or indirect competition across all of the common fundamentals between Bionomics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bionomics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Bionomics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Bionomics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Bionomics to competition |
| Fundamentals | Bionomics | Peer Average |
| Return On Equity | -0.78 | -0.31 |
| Return On Asset | -0.4 | -0.14 |
| Operating Margin | 89.10 % | (5.51) % |
| Current Valuation | (2.01 M) | 16.62 B |
| Shares Outstanding | 19.53 M | 571.82 M |
| Shares Owned By Insiders | 33.91 % | 10.09 % |
| Shares Owned By Institutions | 16.22 % | 39.21 % |
| Number Of Shares Shorted | 384.28 K | 4.71 M |
| Price To Book | 0.34 X | 9.51 X |
| Price To Sales | 386.72 X | 11.42 X |
| Revenue | 20 K | 9.43 B |
| Gross Profit | (18.96 M) | 27.38 B |
| EBITDA | (9.84 M) | 3.9 B |
| Net Income | (15.49 M) | 570.98 M |
| Cash And Equivalents | 33.56 M | 2.7 B |
| Cash Per Share | 4.46 X | 5.01 X |
| Total Debt | 272.74 K | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 12.46 X | 2.16 X |
| Book Value Per Share | 1.32 X | 1.93 K |
| Cash Flow From Operations | (14.68 M) | 971.22 M |
| Short Ratio | 0.13 X | 4.00 X |
| Earnings Per Share | (1.19) X | 3.12 X |
| Target Price | 15.37 | |
| Number Of Employees | 8 | 18.84 K |
| Beta | -0.069 | -0.15 |
| Market Capitalization | 5.82 M | 19.03 B |
| Total Asset | 18.96 M | 29.47 B |
| Retained Earnings | (177.98 M) | 9.33 B |
| Working Capital | 9.36 M | 1.48 B |
| Net Asset | 18.96 M |
Note: Disposition of 100000 shares by Wilson David Ian of Bionomics at 0.2866 subject to Rule 16b-3 [view details]
Bionomics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bionomics . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Bionomics Buy or Sell Advice
When is the right time to buy or sell Bionomics Ltd ADR? Buying financial instruments such as Bionomics Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Bionomics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Global Macro ETFs Thematic Idea Now
Global Macro ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Global Macro ETFs theme has 26 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Global Macro ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Bionomics Stock Analysis
When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.